Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). metaEvidence.org method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical improvement | clinical worsening | deaths | PCR-negative conversion | |||
| alpha lipoic acid | - | - | 0.17 [0.02; 1.44], 1 study, I2=0% inconclusive result | - | ||
| acetylcysteine | 0 | - | - | - | - | |
| aviptadil | 0 | - | - | - | - | |
| bevacizumab | 0 | - | - | - | - | |
| bismuth | 0 | - | - | - | - | |
| BLD-2660 (calpain inhibitor) | 0 | - | - | - | - | |
| camostat mesilate | 0 | - | - | - | - | |
| continuous positive airway pressure (CPAP) | 0 | - | - | - | - | |
| cytokine adsorption | 0 | - | - | - | - | |
| diammonium glycyrrhizinate | 0 | - | - | - | - | |
| dipyridamol | 0 | - | - | - | - | |
| DPP-4 inhibitor | 0 | - | - | - | - | |
| enoxaparin | 0 | - | - | - | - | |
| levamisole | 0 | - | - | - | - | |
| natural killer (NK) cells | 0 | - | - | - | - | |
| nicotin | 0 | - | - | - | - | |
| nitric oxide (gas Inhalation or releasing solution) | 0 | - | - | - | - | |
| ozonated autohemotherapy | 0 | - | - | - | - | |
| pamrevlumab | 0 | - | - | - | - | |
| prone positioning | 0 | - | - | - | - | |
| PUL-042 inhalation solution | 0 | - | - | - | - | |
| selinexor | 0 | - | - | - | - | |
| stem cells | 0 | - | - | - | - | |
| tradipitant | 0 | - | - | - | - | |
| tranilast | 0 | - | - | - | - | |
-
About us
-
Credits
-
method
Made with in Lyon
-
Contact us
-
Privacy policy
-
